Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Pawel Muranski(National Cancer Institute), Nicholas P. Restifo(National Cancer Institute)
Cited by 348
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
|JCI Insight|2017|221
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
|bioRxiv (Cold Spring Harbor Laboratory)|2020|15